Related references
Note: Only part of the references are listed.Bilateral vestibulopathy in anti-IgLON5 disease
Christoph Helmchen et al.
JOURNAL OF NEUROLOGY (2021)
Distribution patterns of tau pathology in progressive supranuclear palsy
Gabor G. Kovacs et al.
ACTA NEUROPATHOLOGICA (2020)
Progressive Supranuclear Palsy-Parkinsonism Predominant (PSP-P)-A Clinical Challenge at the Boundaries of PSP and Parkinson's Disease (PD)
Piotr Alster et al.
FRONTIERS IN NEUROLOGY (2020)
Microglial Activation and Inflammation as a Factor in the Pathogenesis of Progressive Supranuclear Palsy (PSP)
Piotr Alster et al.
FRONTIERS IN NEUROSCIENCE (2020)
A Cortical Substrate for Square-Wave Jerks in Progressive Supranuclear Palsy
Evangelos Anagnostou et al.
JOURNAL OF CLINICAL NEUROLOGY (2020)
How to spot ocular abnormalities in progressive supranuclear palsy? A practical review
Onanong Phokaewvarangkul et al.
TRANSLATIONAL NEURODEGENERATION (2019)
No Evidence of a Contribution of the Vestibular System to Frequent Falls in Progressive Supranuclear Palsy
Nicolina Goldschagg et al.
JOURNAL OF CLINICAL NEUROLOGY (2019)
IgLON5: A case with predominant cerebellar tau deposits and leptomeningeal inflammation
Florian Schoeberl et al.
NEUROLOGY (2018)
IgLON5-mediated neurodegeneration is a differential diagnosis of CNS Whipple disease
Hugo Morales-Briceno et al.
NEUROLOGY (2018)
Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology
Bettina Balint et al.
BRAIN (2018)
IgLON5 autoimmunity tested negative in patients with progressive supranuclear palsy and corticobasal syndrome
Stephanie Mangesius et al.
PARKINSONISM & RELATED DISORDERS (2017)
IgLON5 antibody Neurological accompaniments and outcomes in 20 patients
Josephe A. Honorat et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
Neuropathological criteria of anti-IgLON5-related tauopathy
Ellen Gelpi et al.
ACTA NEUROPATHOLOGICA (2016)
Chorea and parkinsonism associated with autoantibodies to IgLON5 and responsive to immunotherapy
Ren Haitao et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
Dystonia, lower limb stiffness, and upward gaze palsy in a patient with IgLON5 antibodies
Norbert Brueggemann et al.
MOVEMENT DISORDERS (2016)
IgLON Cell Adhesion Molecules Are Shed from the Cell Surface of Cortical Neurons to Promote Neuronal Growth
Ricardo Sanz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study (vol 13, pg 575, 2014)
L. Sabater et al.
LANCET NEUROLOGY (2015)
A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to lgLON5: a case series, characterisation of the antigen, and post-mortem study
Lidia Sabater et al.
LANCET NEUROLOGY (2014)
Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson's disease
Svenja Marx et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2012)
In vivo comparison of Richardson's syndrome and progressive supranuclear palsy-parkinsonism
Karin Srulijes et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Differential diagnostic value of eye movement recording in PSP-parkinsonism, Richardson's syndrome, and idiopathic Parkinson's disease
Elmar H. Pinkhardt et al.
JOURNAL OF NEUROLOGY (2008)
Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy
Kurt A. Jellinger
NEURODEGENERATIVE DISEASES (2008)
Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome
David R. Williams et al.
BRAIN (2007)
Diglons are heterodimeric proteins composed of IgLON subunits, and Diglon-CO inhibits neurite outgrowth from cerebellar granule cells
J Reed et al.
JOURNAL OF CELL SCIENCE (2004)
Share Paper
